These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12205440)

  • 21. Hunter-gatherers win profit-sharing deal for obesity drug.
    Wise J
    Bull World Health Organ; 2003; 81(5):382. PubMed ID: 12856057
    [No Abstract]   [Full Text] [Related]  

  • 22. Constitutional issues raised by states' exclusion of fertility drugs from Medicaid coverage in light of mandated coverage of Viagra.
    Connolly EL
    Vanderbilt Law Rev; 2001 Mar; 54(2):451-80. PubMed ID: 16485375
    [No Abstract]   [Full Text] [Related]  

  • 23. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 24. Obesity: new perspectives and pharmacotherapies.
    Palamara KL; Mogul HR; Peterson SJ; Frishman WH
    Cardiol Rev; 2006; 14(5):238-58. PubMed ID: 16924165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Out of sight. Pharmaceutical industry temporarily replaces hospitals as target.
    McLaughlin N
    Mod Healthc; 2004 Oct; 34(42):26. PubMed ID: 15552190
    [No Abstract]   [Full Text] [Related]  

  • 26. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 27. In search of fat profits.
    Watts G
    BMJ; 2007 Jun; 334(7607):1298-9. PubMed ID: 17585156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin V.
    Hallberg J
    Minn Med; 2003 Jul; 86(7):18-9. PubMed ID: 12921371
    [No Abstract]   [Full Text] [Related]  

  • 29. The misuse of antibiotics.
    Levy SB; Star L; Kupferberg ED
    Med Ethics (Burlingt Mass); 2004; 11(1):5-8. PubMed ID: 15915579
    [No Abstract]   [Full Text] [Related]  

  • 30. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 31. The pharmaceutical market for obesity therapies.
    Wong D; Sullivan K; Heap G
    Nat Rev Drug Discov; 2012 Sep; 11(9):669-70. PubMed ID: 22935797
    [No Abstract]   [Full Text] [Related]  

  • 32. Controversial AIDS drug for US market.
    Barinaga M
    Nature; 1988 Apr; 332(6164):475. PubMed ID: 3357506
    [No Abstract]   [Full Text] [Related]  

  • 33. Cialis is here. The soft sell.
    Naughton K
    Newsweek; 2004 Feb; 143(5):46-7. PubMed ID: 14974376
    [No Abstract]   [Full Text] [Related]  

  • 34. First PDE4 inhibitor for psoriasis hits the market but impact is uncertain.
    Ratner M
    Nat Biotechnol; 2014 Jun; 32(6):505-7. PubMed ID: 24911477
    [No Abstract]   [Full Text] [Related]  

  • 35. Lifestyle key factor in marketing residential care services.
    Kane J
    Provider; 1989 Jan; 15(1):40, 42. PubMed ID: 10291302
    [No Abstract]   [Full Text] [Related]  

  • 36. Move over, Viagra.
    Gupta S
    Time; 2003 Sep; 162(9):66. PubMed ID: 12964401
    [No Abstract]   [Full Text] [Related]  

  • 37. Resurrecting the resurrection drug.
    Wickware P
    Nat Med; 2002 Sep; 8(9):908-9. PubMed ID: 12205439
    [No Abstract]   [Full Text] [Related]  

  • 38. Futurespeak. Interview by Alison Stein Wellner.
    Smith D
    Am Demogr; 2001 Jan; 12(1):65. PubMed ID: 11503750
    [No Abstract]   [Full Text] [Related]  

  • 39. Roche consolidates grip on anti-angiogenesis market.
    Moran N
    Nat Biotechnol; 2008 Oct; 26(10):1055-6. PubMed ID: 18846054
    [No Abstract]   [Full Text] [Related]  

  • 40. ED drugs covered, but managed care unmoved.
    Manag Care; 2005 Mar; 14(3):64. PubMed ID: 15825613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.